AMA Ed Hub Logo

Learn more on prescription drugs from AMA Ed Hub™
Red JAMA Logo

Learn more on prescription drugs from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on prescription drugs from PolicyFinder
United States Adopted Names Council

United States Adopted Names (USAN)
Clear Search
·
1 Min Read

AMA urges EpiPen manufacturer to rein in exorbitant costs

"Statement attributable to: Andrew W. Gurman, M.D. President, American Medical Association"

Press Releases
·
7 Min Read

Helping patients by using prescription drug monitoring programs

Prescription drug monitoring programs can be an effective tool for helping patients. One physician uses his PDMP to inform treatment options and discuss safety issues with patients.

Behavioral Health
·
6 Min Read

AMA guide for media reporting on "open payments" data release

Media should verify the accuracy of data; understand the context of financial relationships between physicians and industry when reporting on open payments data.

Press Releases
·
7 Min Read

3 things physicians should do when treating pain

Physicians treating patients with acute or chronic pain can benefit from 3 suggestions: use state PDMPs to improve care; focus on the patient’s goals not just the pain; and talk about overdose risk.

Behavioral Health
·
5 Min Read

Physicians take steps to address opioid overdose epidemic

New policies adopted by the AMA address steps physicians can take to fight opioid overdose epidemic. Efforts cover the use of prescription drug monitoring programs; access to naloxone and adding addiction medicine as a sub-specialty.

Behavioral Health
·
2 Min Read

Physicians confront the rise of “smart drugs”

Safety concerns generated by a growing use of nootropics prompted the AMA to adopt new policy discouraging the nonmedical use of these prescription drugs for cognitive enhancement in healthy individuals.

Behavioral Health
·
3 Min Read

AMA confronts the rise of nootropics

Responding to the growing personal use of nootropics, AMA physicians today adopted policy to discourage nonmedical use of drugs for cognitive enhancement.

Press Releases
·
2 Min Read

Medicare financial data going public: Review yours now

Physicians have until May 15 to review and dispute reports about financial interactions with manufacturers of drugs and medical devices reported under the the Open Payments program.

Medicare & Medicaid
National Advocacy Conference panel
·
5 Min Read

Experts explain high drug prices, offer solutions

Addressing the rising cost of prescription drugs, 3 experts in the pharmaceuticals field discuss marketplace trends affecting drug spending and pricing. They also discuss solutions to address drug prices and availability.

Behavioral Health